A study of PARG inhibitor IDE161 in participants with advanced solid tumors

Disease:

Advanced or Metastatic Solid Tumors, Breast Cancer, Ovarian Cancer, Prostate Cancer, Endometrial Cancer, Colorectal Cancer, Head and Neck Cancers, Nsclc

Study phase:

Phase I

Physician name:

Timothy Yap

Department:

Investigational Cancer Therapeutics

For general questions about clinical trials:

1-888-994-0731